These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2008903)

  • 41. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation.
    Kumar R; Ghoshal UC; Singh G; Mittal RD
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1403-9. PubMed ID: 15610315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of commercial kidney stone probiotic supplements.
    Ellis ML; Shaw KJ; Jackson SB; Daniel SL; Knight J
    Urology; 2015 Mar; 85(3):517-21. PubMed ID: 25733259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of heterologous oxalate decarboxylase in HEK293 cells confers protection against oxalate induced oxidative stress as a therapeutic approach for calcium oxalate stone disease.
    Albert A; Tiwari V; Paul E; Ganesan D; Ayyavu M; Kujur R; Ponnusamy S; Shanmugam K; Saso L; Govindan Sadasivam S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):426-433. PubMed ID: 28118755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microorganisms and calcium oxalate stone disease.
    Goldfarb DS
    Nephron Physiol; 2004; 98(2):p48-54. PubMed ID: 15499215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and characterization of oxalyl-coenzyme A decarboxylase from Oxalobacter formigenes.
    Baetz AL; Allison MJ
    J Bacteriol; 1989 May; 171(5):2605-8. PubMed ID: 2708315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new era in the treatment of calcium oxalate stones?
    Ivanovski O; Drüeke TB
    Kidney Int; 2013 Jun; 83(6):998-1000. PubMed ID: 23728004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection and characterization of merohedral twinning in crystals of oxalyl-coenzyme A decarboxylase from Oxalobacter formigenes.
    Berthold CL; Sidhu H; Ricagno S; Richards NG; Lindqvist Y
    Biochim Biophys Acta; 2006 Jan; 1764(1):122-8. PubMed ID: 16198641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Hoppe B; von Unruh G; Laube N; Hesse A; Sidhu H
    Urol Res; 2005 Nov; 33(5):372-5. PubMed ID: 16284877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of oxalyl-CoA decarboxylase (oxc) and formyl-CoA transferase (frc) genes in novel probiotic isolates capable of oxalate degradation in vitro.
    Youssef HIA
    Folia Microbiol (Praha); 2024 Apr; 69(2):423-432. PubMed ID: 38217756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.
    Holmes RP; Knight J; Assimos DG
    Urolithiasis; 2016 Feb; 44(1):27-32. PubMed ID: 26614109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of antibiotics and risk of kidney stones.
    Joshi S; Goldfarb DS
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):311-315. PubMed ID: 31145705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of gut microbiota against calcium oxalate.
    Sadaf H; Raza SI; Hassan SW
    Microb Pathog; 2017 Aug; 109():287-291. PubMed ID: 28624518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection and identification of oxalate-degrading bacteria in human feces.
    Kodama T; Akakura K; Mikami K; Ito H
    Int J Urol; 2002 Jul; 9(7):392-7. PubMed ID: 12165021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variability of Oxalobacter formigenes and oxalate in stool samples.
    Prokopovich S; Knight J; Assimos DG; Holmes RP
    J Urol; 2007 Nov; 178(5):2186-90. PubMed ID: 17870112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxalobacter formigenes Colonization and Oxalate Dynamics in a Mouse Model.
    Li X; Ellis ML; Knight J
    Appl Environ Microbiol; 2015 Aug; 81(15):5048-54. PubMed ID: 25979889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium Oxalate Urolithiasis: A Case of Missing Microbes?
    Batagello CA; Monga M; Miller AW
    J Endourol; 2018 Nov; 32(11):995-1005. PubMed ID: 29808727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.